CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- Open-market buys, last 90 days
- $99,331
- in 1 filing
- Open-market sales, last 90 days
- $378,930
- in 4 filings, $379K under 10b5-1 plans
Net −$279,599. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 92 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-15 | Barber Daniel President and CEO | Sale 10b5-1 | −25,000 | $4.22 | $106K | 627,317 |
| 2026-09-15 | Barber Daniel President and CEO | Sale 10b5-1 | −25,000 | $4.82 | $120K | 652,317 |
| 2026-09-09 | Korczynski Sherry Chief Commercial Officer | Sale 10b5-1 | −8,750 | $5.22 | $46K | 235,689 |
| 2026-08-17 | Barber Daniel President and CEO | Sale 10b5-1 | −25,000 | $4.29 | $107K | 585,574 |
| 2026-07-16 | Barber Daniel President and CEO | Sale 10b5-1 | −20,369 | $4.00 | $82K | 610,574 |
| 2026-07-15 | Barber Daniel President and CEO | Sale 10b5-1 | −4,631 | $4.03 | $19K | 630,943 |
| 2026-06-23 | Krop Julie Director | Sale 10b5-1 | −25,000 | $5.02 | $125K | 0 |
| 2026-06-15 | Barber Daniel President and CEO | Sale 10b5-1 | −25,000 | $4.16 | $104K | 635,574 |
| 2026-05-15 | Barber Daniel President and CEO | Sale 10b5-1 | −8,257 | $4.29 | $35K | 660,574 |
| 2026-03-10 | Boyd Peter E. Chief People Officer | Sale | −29,814 | $4.17 | $124K | 338,509 |
| 2026-03-10 | Barber Daniel President and CEO | Sale | −180,677 | $4.17 | $754K | 1,004,753 |
| 2026-03-10 | BRAENDER LORI J Chief Legal Officer | Sale | −40,102 | $4.17 | $167K | 442,879 |
| 2026-03-10 | Cioffi Melina SVP, Regulatory Affairs | Sale | −25,311 | $4.17 | $106K | 274,867 |
| 2026-03-10 | TOTH A ERNEST JR Chief Financial Officer | Sale | −58,254 | $4.17 | $243K | 376,112 |
| 2026-03-10 | Korczynski Sherry Chief Commercial Officer | Sale | −15,741 | $4.17 | $66K | 241,117 |
| 2026-03-10 | Jung Cassie Chief Operating Officer | Sale | −45,791 | $4.17 | $191K | 274,980 |
| 2025-10-15 | Jung Cassie Chief Operating Officer | Sale 10b5-1 | −67,575 | $7.01 | $474K | 240,771 |
| 2025-10-15 | Kraus Carl N Chief Medical Officer | Sale 10b5-1 | −20,272 | $7.00 | $142K | 282,475 |
| 2025-10-15 | Boyd Peter E. See Remarks | Sale 10b5-1 | −10,000 | $7.00 | $70K | 268,323 |
| 2025-09-26 | Barber Daniel President and CEO | Sale 10b5-1 | −91,343 | $6.03 | $551K | 923,430 |
Page 1 of 2 · 35 trades